Paper3548841
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies.
Blume KG and 9 others. Blood, 1987. Cited by 243 papers, by iCite.
Cite this record
ConductScience Library. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Papers, record 3548841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3548841
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow Transplantation | Major topic |
| Etoposide | Major topic |
| Leukemia | Major topic |
| Acute Disease | |
| Adult | |
| Child | |
| Combined Modality Therapy | |
| Dose-Response Relationship, Drug | |
| Drug Evaluation | |
| Graft vs Host Disease | |
| Humans | |
| Infant | |
| Metabolic Clearance Rate | |
| Whole-Body Irradiation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 30206 | NCI NIH HHS | United States | P01CA030206 | PubMed and NIH | NIH RePORTER |
| CA 33572 | NCI NIH HHS | United States | P30CA033572 | PubMed and NIH | NIH RePORTER |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 243 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41407462 | [Autologous hematopoietic stem cell transplantation with TBE conditioning in patients with primary central nervous system lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2025 | https://conductscience.org/library/papers/41407462 | PubMed |
| 39147891 | Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings. | Bone Marrow Transplant | 2024 | https://conductscience.org/library/papers/39147891 | PubMed |
| 39134959 | Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39134959 | PubMed |
| 34150068 | The effects of comprehensive nursing interventions on the negative emotions, quality of life, and nursing satisfaction in intracerebral hemorrhage patients. | Am J Transl Res | 2021 | https://conductscience.org/library/papers/34150068 | PubMed |
| 32035275 | Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. | Biol Blood Marrow Transplant | 2020 | https://conductscience.org/library/papers/32035275 | PubMed |
| 31152565 | Technical Note: Quality assurance and relative dosimetry testing of a 60 Co total body irradiator using optical imaging. | Med Phys | 2019 | https://conductscience.org/library/papers/31152565 | PubMed |
| 31027384 | Perspectives on the Use of a Medium-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation: The Japanese Experience from 1993 to Present. | J Clin Med | 2019 | https://conductscience.org/library/papers/31027384 | PubMed |
| 30806963 | Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia. | Curr Hematol Malig Rep | 2019 | https://conductscience.org/library/papers/30806963 | PubMed |
| 26367236 | Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL). | Bone Marrow Transplant | 2015 | https://conductscience.org/library/papers/26367236 | PubMed |
| 26322249 | Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning. | Exp Hematol Oncol | 2015 | https://conductscience.org/library/papers/26322249 | PubMed |
| 26040247 | Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse. | Arch Immunol Ther Exp (Warsz) | 2015 | https://conductscience.org/library/papers/26040247 | PubMed |
| 25408851 | Role of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia. | Mediterr J Hematol Infect Dis | 2014 | https://conductscience.org/library/papers/25408851 | PubMed |
| 24077846 | Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance). | Haematologica | 2014 | https://conductscience.org/library/papers/24077846 | PubMed |
| 22234252 | Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults. | Curr Opin Oncol | 2012 | https://conductscience.org/library/papers/22234252 | PubMed |
| 21224011 | National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee. | Biol Blood Marrow Transplant | 2011 | https://conductscience.org/library/papers/21224011 | PubMed |
| 20531287 | Autologous hematopoietic cell transplantation for high-risk ALL. | Bone Marrow Transplant | 2011 | https://conductscience.org/library/papers/20531287 | PubMed |
| 20062098 | Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX. | Bone Marrow Transplant | 2010 | https://conductscience.org/library/papers/20062098 | PubMed |
| 19786984 | Cyclophosphamide and cancer: golden anniversary. | Nat Rev Clin Oncol | 2009 | https://conductscience.org/library/papers/19786984 | PubMed |
| 19244158 | Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. | Blood | 2009 | https://conductscience.org/library/papers/19244158 | PubMed |
| 18519812 | Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. | Blood | 2008 | https://conductscience.org/library/papers/18519812 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3548841
GET https://conductscience.org/api/papers/v1/3548841/cited_by?page=2